{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:03:32Z","timestamp":1761541412481,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.brachy.2017.11.001","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T23:46:30Z","timestamp":1512171990000},"page":"383-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer\u2014Brachytherapy may be sufficient"],"prefix":"10.1016","volume":"17","author":[{"given":"Chika R.","family":"Nwachukwu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Von-Eyben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2017.11.001_bib1","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2017.11.001_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.brachy.2017.11.001_bib3","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynecol Obstet"},{"author":"Howlader","key":"10.1016\/j.brachy.2017.11.001_bib4"},{"key":"10.1016\/j.brachy.2017.11.001_bib5","first-page":"1540","article-title":"Postoperative radiotherapy in stage I\/II endometrial cancer","volume":"20","author":"Scotti","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2017.11.001_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2013.11.003","article-title":"Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma","volume":"88","author":"Elshaikh","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.001_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2014.04.008","article-title":"Gynecologic oncology adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib \u2013 II endometrial cancer\u202f: An Italian multicenter retrospective study (CTF study)","volume":"134","author":"Gadducci","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/gyno.2001.6130","article-title":"Postoperative vaginal vault brachytherapy for node-negative Stage II (occult) endometrial carcinoma","volume":"81","author":"Ng","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ygyno.2005.04.030","article-title":"Stage II endometrial carcinoma: Limiting post-operative radiotherapy to the vaginal vault in node-negative tumors","volume":"98","author":"Rittenberg","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2008.12.029","article-title":"Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma","volume":"113","author":"Cannon","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.brachy.2015.02.196","article-title":"Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?","volume":"14","author":"Paydar","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2017.11.001_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2014.12.012","article-title":"Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution study","volume":"136","author":"Elshaikh","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COC.0b013e3181b0c266","article-title":"Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?","volume":"33","author":"Crosby","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2012.04.013","article-title":"Cardiovascular disease is the leading cause of death among endometrial cancer patients","volume":"126","author":"Ward","year":"2012","journal-title":"Gynecol Oncol"},{"year":"1990","series-title":"Statistical inference","author":"Casella","key":"10.1016\/j.brachy.2017.11.001_bib16"},{"key":"10.1016\/j.brachy.2017.11.001_bib17","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.brachy.2017.11.001_bib18","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djt279","article-title":"Cause-specific effects of radiotherapy and lymphadenectomy in Stage I\u2013II endometrial cancer: A Population-Based Study","volume":"105","author":"Mell","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2017.11.001_bib19","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0360-3016(01)01765-5","article-title":"The morbidity of treatment for patients with stage I endometrial cancer: Results from a randomized trial","volume":"51","author":"Creutzberg","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.001_bib20","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib21","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2016.06.024","article-title":"A phase III randomized trial comparing patient-reported toxicity and quality of life (QOL) during pelvic intensity modulated radiation therapy as compared to conventional radiation therapy","volume":"96","author":"Klopp","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib22","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: First results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2017.11.001_bib24","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The postoperative radiation therapy in endometrial carcinoma trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0360-3016(90)90477-2","article-title":"Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium","volume":"19","author":"Greven","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.001_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/COC.0000000000000065","article-title":"Adjuvant pelvic radiation therapy\u00a0+ vaginal brachytherapy in patients with high-risk stage I or stage II uterine papillary serous, clear cell, and high-grade endometrioid carcinoma","volume":"39","author":"Nagar","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(98)00173-4","article-title":"Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?","volume":"42","author":"Greven","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2017.11.001_bib28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","article-title":"A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy (VCB\/C) in patients with high risk (HR), early stage endometrial cancer (EC)","volume":"134","author":"McMeekin","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib29","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1200\/JCO.2017.35.15_suppl.5502","article-title":"Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer","volume":"35","author":"De Boer","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib30","doi-asserted-by":"crossref","first-page":"457.e1","DOI":"10.1016\/j.ajog.2008.01.010","article-title":"Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?","volume":"198","author":"Abu-Rustum","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.brachy.2017.11.001_bib31","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.22185","article-title":"Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients","volume":"107","author":"Chan","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2017.11.001_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1995.1005","article-title":"Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling","volume":"56","author":"Kilgore","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib33","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2017.11.001_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jjco\/hys019","article-title":"Systematic lymphadenectomy for survival in patients with endometrial cancer: A meta-analysis Systematic-lymphadenectomy-for-survival-in","volume":"42","author":"Kim","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.brachy.2017.11.001_bib35","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2017.11.001_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117305196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472117305196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:13:46Z","timestamp":1761531226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472117305196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1538472117305196"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2017.11.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer\u2014Brachytherapy may be sufficient","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2017.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}